Autopsy report · NCT00528827

A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension

“Due to the sale of Cardene IV, the sponsor has stopped enrollment and withdrawn the study. No safety issues were identified.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Facet Biotech

Sponsor type

Industry

Conditions

Hypertension

Interventions

Cardene® I.V.

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
  “Study has been stopped by sponsor decision.” (75% match in meaning)
• CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
  “Sponsor stopped the study.” (74% match in meaning)
• Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum
  “The sponsor stopped the study.” (73% match in meaning)
• Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)
  “The sponsor has decided to stop the study” (73% match in meaning)
• the Health Crisis at the Healthcare Professionals, Careers and Non-careers, a Month After the Containment Period
  “the sponsor decided to stop the study” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.